Triodos Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Akamai
AKAM
|
+$29M |
| 2 |
NVIDIA
NVDA
|
+$28.9M |
| 3 |
Intuitive Surgical
ISRG
|
+$10.7M |
| 4 |
Acuity Brands
AYI
|
+$2.54M |
| 5 |
Power Integrations
POWI
|
+$2.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$5.41M |
| 2 |
Strategic Education
STRA
|
+$1.66M |
| 3 |
TSMC
TSM
|
+$342K |
| 4 |
Starbucks
SBUX
|
+$323K |
| 5 |
VF Corp
VFC
|
+$176K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.83% |
| 2 | Healthcare | 19.27% |
| 3 | Industrials | 11.54% |
| 4 | Consumer Staples | 10.71% |
| 5 | Consumer Discretionary | 8.19% |
Similar funds
Triodos Investment Management's Q2 2022 Portfolio in Review
As of Q2 2022, Triodos Investment Management held 48 positions worth $710M, down 9.3% from $783M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Triodos Investment Management deployed $83.1M of net new capital in Q2 2022, opening 11 new positions and adding to 19 existing holdings. Its largest new stake was Akamai: 278,250 shares worth $25.4M.
By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 44% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Strategic Education, an estimated $1.66M trimmed.
- Triodos Investment Management's largest Q2 2022 buy was Akamai: 278,250 shares worth $25.4M.
- Triodos Investment Management added most to Intuitive Surgical in Q2 2022, an estimated $10.7M increase.
- Triodos Investment Management's biggest Q2 2022 reduction was Strategic Education, cutting an estimated $1.66M.
- Triodos Investment Management fully exited Teladoc Health in Q2 2022, selling an estimated $5.41M.
- Triodos Investment Management's ten largest holdings make up 46% of its $710M portfolio in Q2 2022.
- Triodos Investment Management opened 11 new positions and closed 1 in Q2 2022.
- Triodos Investment Management's portfolio value fell 9.3% quarter-over-quarter to $710M.
Based on Triodos Investment Management's 13F filing for Q2 2022, filed 8 Aug 2022.